MF
Michelle Frazier
Senior Vice President of RegulatoryDr. Michelle Frazier, Ph.D., is Senior Vice President of Regulatory of Coya Therapeutics, Inc. and served as its Senior Vice President of Regulatory Affairs from June 2023. Dr. Frazier is Senior Vice President of Regulatory Affairs of Coya Therapeutics, Inc. from June 2023. Dr. Frazier leverage her regulatory and CMC expertise to guide and oversee all of Coya's regulatory submissions including the upcoming IND submission for COYA 302 for the treatment of Amyotrophic Lateral Sclerosis. Dr. Frazier has B.S. in Microbiology from Washington State University and. a Ph.D in cell biology from Loyola University.
Positions
- Company NameCoya Therapeutics, Inc.Stock CodeCOYAPositionSenior Vice President of RegulatoryColleagues
- ASArun SwaminathanCEO & Director
- FGFred GrossmanPresident & Chief Medical Officer
- DSDavid S. SnyderCFO & COO
- ATAaron ThomeHead of Neuroinflammation Platform
- AVAnabella VillalobosIndependent Director
- DADov A. GoldsteinIndependent Director
- DWDieter WeinandIndependent Director
- ALAnn L. LeeIndependent Director
